At CRISPR QC, we're working to empower the scientists, researchers, and doctors at the front lines of the genetic engineering revolution. Our CRISPR Analytics Platform provides the data and insights they need to power the safest, most efficacious gene editing outcomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/11/23 | $1,600,000 | Seed |
CaerusX Ventures Serra Ventures  | undisclosed |
| 01/04/24 | undisclosed | Series A |
Xcellerant Ventures | undisclosed |
